Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae
- PMID:24639510
- PMCID: PMC3977278
- DOI: 10.1073/pnas.1321364111
Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae
Abstract
Infections caused by drug-resistant bacteria are a major problem worldwide. Carbapenem-resistant Klebsiella pneumoniae, most notably isolates classified as multilocus sequence type (ST) 258, have emerged as an important cause of hospital deaths. ST258 isolates are predominantly multidrug resistant, and therefore infections caused by them are difficult to treat. It is not known why the ST258 lineage is the most prevalent cause of multidrug-resistant K. pneumoniae infections in the United States and other countries. Here we tested the hypothesis that carbapenem-resistant ST258 K. pneumoniae is a single genetic clone that has disseminated worldwide. We sequenced to closure the genomes of two ST258 clinical isolates and used these genomes as references for comparative genome sequencing of 83 additional clinical isolates recovered from patients at diverse geographic locations worldwide. Phylogenetic analysis of the SNPs in the core genome of these isolates revealed that ST258 K. pneumoniae organisms are two distinct genetic clades. This unexpected finding disproves the single-clone hypothesis. Notably, genetic differentiation between the two clades results from an ∼ 215-kb region of divergence that includes genes involved in capsule polysaccharide biosynthesis. The region of divergence appears to be a hotspot for DNA recombination events, and we suggest that this region has contributed to the success of ST258 K. pneumoniae. Our findings will accelerate research on novel diagnostic, therapeutic, and vaccine strategies designed to prevent and/or treat infections caused by multidrug resistant K. pneumoniae.
Keywords: Enterobacteriaceae; antibiotic resistance; carbapenemase; plasmid.
Conflict of interest statement
Conflict of interest statement: B.N.K. holds two patents that focus on using DNA sequencing to identify bacterial pathogens.
Figures




Similar articles
- Epidemic Klebsiella pneumoniae ST258 is a hybrid strain.Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN.Chen L, et al.mBio. 2014 Jun 24;5(3):e01355-14. doi: 10.1128/mBio.01355-14.mBio. 2014.PMID:24961694Free PMC article.
- Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258Klebsiella pneumoniae.Holden VI, Wright MS, Houle S, Collingwood A, Dozois CM, Adams MD, Bachman MA.Holden VI, et al.mSphere. 2018 Apr 18;3(2):e00125-18. doi: 10.1128/mSphere.00125-18. Print 2018 Apr 25.mSphere. 2018.PMID:29669884Free PMC article.
- Clonal diversity and genetic profiling of antibiotic resistance among multidrug/carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary care hospital in Saudi Arabia.Zaman TU, Alrodayyan M, Albladi M, Aldrees M, Siddique MI, Aljohani S, Balkhy HH.Zaman TU, et al.BMC Infect Dis. 2018 May 3;18(1):205. doi: 10.1186/s12879-018-3114-9.BMC Infect Dis. 2018.PMID:29724185Free PMC article.
- Antibody-Mediated Killing of Carbapenem-Resistant ST258Klebsiella pneumoniae by Human Neutrophils.Kobayashi SD, Porter AR, Freedman B, Pandey R, Chen L, Kreiswirth BN, DeLeo FR.Kobayashi SD, et al.mBio. 2018 Mar 13;9(2):e00297-18. doi: 10.1128/mBio.00297-18.mBio. 2018.PMID:29535199Free PMC article.
- Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.Gomez-Simmonds A, Uhlemann AC.Gomez-Simmonds A, et al.J Infect Dis. 2017 Feb 15;215(suppl_1):S18-S27. doi: 10.1093/infdis/jiw378.J Infect Dis. 2017.PMID:28375514Free PMC article.Review.
Cited by
- Extensive Capsule Locus Variation and Large-Scale Genomic Recombination within the Klebsiella pneumoniae Clonal Group 258.Wyres KL, Gorrie C, Edwards DJ, Wertheim HF, Hsu LY, Van Kinh N, Zadoks R, Baker S, Holt KE.Wyres KL, et al.Genome Biol Evol. 2015 Apr 10;7(5):1267-79. doi: 10.1093/gbe/evv062.Genome Biol Evol. 2015.PMID:25861820Free PMC article.
- Identification of a novel CG307 sub-clade in third-generation-cephalosporin-resistantKlebsiella pneumoniae causing invasive infections in the USA.Selvaraj Anand S, Wu CT, Bremer J, Bhatti M, Treangen TJ, Kalia A, Shelburne SA, Shropshire WC.Selvaraj Anand S, et al.Microb Genom. 2024 Feb;10(2):001201. doi: 10.1099/mgen.0.001201.Microb Genom. 2024.PMID:38407244Free PMC article.
- Exploiting genomics to mitigate the public health impact of antimicrobial resistance.Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S.Waddington C, et al.Genome Med. 2022 Feb 16;14(1):15. doi: 10.1186/s13073-022-01020-2.Genome Med. 2022.PMID:35172877Free PMC article.Review.
- CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.Eilertson B, Chen L, Li A, Chavda KD, Chavda B, Kreiswirth BN.Eilertson B, et al.J Antimicrob Chemother. 2019 Jan 1;74(1):17-21. doi: 10.1093/jac/dky394.J Antimicrob Chemother. 2019.PMID:30272172Free PMC article.
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani T, Errico G, Aspbury M, Sjunnebo S; EuSCAPE Working Group; ESGEM Study Group; Feil EJ, Rossolini GM, Aanensen DM, Grundmann H.David S, et al.Nat Microbiol. 2019 Nov;4(11):1919-1929. doi: 10.1038/s41564-019-0492-8. Epub 2019 Jul 29.Nat Microbiol. 2019.PMID:31358985Free PMC article.
References
- Ben-David D, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- SRA/SRP036874
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases